Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125425101 | 12542510 | 1 | I | 20140331 | 20160709 | 20160709 | EXP | US-CIPLA LTD.-2014US00340 | CIPLA | KHAN AM, KHAN S, DAVE V, BHURGRI H.. SMALL CELL LUNG CARCINOMA PRESENTING AS A CAECAL POLYP ON SURVEILLANCE COLONOSCOPY. BMJ CASE REP.. 2014;1 TO 4 | 0.00 | Y | 0.00000 | 20160709 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125425101 | 12542510 | 1 | PS | CARBOPLATIN. | CARBOPLATIN | 1 | UNK | 0 | |||||||||||
| 125425101 | 12542510 | 2 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | UNK | 0 | |||||||||||
| 125425101 | 12542510 | 3 | SS | Zoledronic acid | ZOLEDRONIC ACID | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125425101 | 12542510 | 4 | C | ALLOPURINOL. | ALLOPURINOL | 1 | Unknown | UNK | U | U | 0 | ||||||||
| 125425101 | 12542510 | 5 | C | Pegfilgrastim | PEGFILGRASTIM | 1 | Unknown | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125425101 | 12542510 | 1 | Small cell lung cancer extensive stage |
| 125425101 | 12542510 | 2 | Small cell lung cancer extensive stage |
| 125425101 | 12542510 | 4 | Prophylaxis |
| 125425101 | 12542510 | 5 | Neutropenia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125425101 | 12542510 | OT |
| 125425101 | 12542510 | HO |
| 125425101 | 12542510 | DE |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125425101 | 12542510 | Anaemia | |
| 125425101 | 12542510 | Back pain | |
| 125425101 | 12542510 | Bone lesion | |
| 125425101 | 12542510 | Death | |
| 125425101 | 12542510 | Disease progression | |
| 125425101 | 12542510 | Dizziness | |
| 125425101 | 12542510 | Extradural neoplasm | |
| 125425101 | 12542510 | Fall | |
| 125425101 | 12542510 | Hepatic failure | |
| 125425101 | 12542510 | Muscular weakness | |
| 125425101 | 12542510 | Paraesthesia | |
| 125425101 | 12542510 | Performance status decreased | |
| 125425101 | 12542510 | Sensory loss |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |